Lowest-Rated StocksLowest-RatedNYSE:FMS Fresenius Medical Care AG & Co. KGaA (FMS) Stock Price, News & Analysis $22.36 +0.13 (+0.56%) Closing price 09/11/2026 03:58 PM EasternExtended Trading$22.35 0.00 (-0.02%) As of 09/11/2026 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Fresenius Medical Care AG & Co. KGaA Stock (NYSE:FMS) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get FMS alerts:Sign Up Key Stats Today's Range$22.25▼$22.5450-Day Range$22.25▼$25.7352-Week Range$20.02▼$27.64Volume584,827 shsAverage Volume594,039 shsMarket Capitalization$12.01 billionP/E Ratio11.58Dividend Yield2.73%Price Target$23.57Consensus RatingReduce Company Overview Fresenius Medical Care AG & Co. KGaA is a Germany-based health care company focused on kidney disease and dialysis services. The company provides hemodialysis and peritoneal dialysis treatments through a global network of outpatient dialysis clinics and supports patients with related care and medical services. In addition to operating dialysis centers, Fresenius Medical Care develops and manufactures products used in renal care. Its portfolio includes dialysis machines, dialyzers, bloodlines, concentrates, solutions, pharmaceuticals and other disposable supplies. The company also offers clinical care, laboratory services and health care solutions connected with chronic kidney disease management. Fresenius Medical Care was established in 1996 through the combination of Fresenius’s dialysis business with National Medical Care. Headquartered in Bad Homburg, Germany, the company serves patients and health care providers across North America, Europe, Asia-Pacific, Latin America and other international markets. Helen Giza serves as chief executive officer.AI Generated. May Contain Errors. Read More Fresenius Medical Care AG & Co. KGaA Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks44th Percentile Overall ScoreFMS MarketRank™: Fresenius Medical Care AG & Co. KGaA scored higher than 44% of companies evaluated by MarketBeat, and ranked 631st out of 904 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.2 / 5Analyst RatingReduce Consensus RatingFresenius Medical Care AG & Co. KGaA has received a consensus rating of Reduce. The company's average rating score is 1.55, and is based on no strong buy ratings, no buy ratings, 6 hold ratings, and 5 sell ratings.Upside/DownsideThe consensus price target for Fresenius Medical Care AG & Co. KGaA is close to its current price, suggesting limited near-term upside or downside.Amount of Analyst CoverageFresenius Medical Care AG & Co. KGaA has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Fresenius Medical Care AG & Co. KGaA's stock forecast and price target. Earnings and Valuation2.5 / 5Proj. Earnings Growth4.44% Earnings GrowthEarnings for Fresenius Medical Care AG & Co. KGaA are expected to grow by 4.44% in the coming year, from $2.25 to $2.35 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Fresenius Medical Care AG & Co. KGaA is 11.58, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 44.90.Price to Earnings Ratio vs. SectorThe P/E ratio of Fresenius Medical Care AG & Co. KGaA is 11.58, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 274.94.Price to Earnings Growth RatioFresenius Medical Care AG & Co. KGaA has a PEG Ratio of 4.15. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioFresenius Medical Care AG & Co. KGaA has a P/B Ratio of 0.77. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Fresenius Medical Care AG & Co. KGaA's valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted0.52% of the float of Fresenius Medical Care AG & Co. KGaA has been sold short.Short Interest Ratio / Days to CoverFresenius Medical Care AG & Co. KGaA has a short interest ratio ("days to cover") of 4.32.Change versus previous monthShort interest in Fresenius Medical Care AG & Co. KGaA has recently increased by 0.64%, indicating that investor sentiment is decreasing. Dividend2.5 / 5Dividend StrengthModerate Dividend YieldFresenius Medical Care AG & Co. KGaA pays a meaningful dividend of 2.71%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthFresenius Medical Care AG & Co. KGaA does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Fresenius Medical Care AG & Co. KGaA is 31.61%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, Fresenius Medical Care AG & Co. KGaA will have a dividend payout ratio of 25.96% next year. This indicates that Fresenius Medical Care AG & Co. KGaA will be able to sustain or increase its dividend.Read more about Fresenius Medical Care AG & Co. KGaA's dividend. News and Social Media0.6 / 5News SentimentN/A Search InterestOnly 1 people have searched for FMS on MarketBeat in the last 30 days. This is a decrease of -88% compared to the previous 30 days.MarketBeat Follows3 people have added Fresenius Medical Care AG & Co. KGaA to their MarketBeat watchlist in the last 30 days. Company Ownership0.1 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Fresenius Medical Care AG & Co. KGaA insiders have not sold or bought any company stock.Percentage Held by Institutions8.37% of the stock of Fresenius Medical Care AG & Co. KGaA is held by institutions.Read more about Fresenius Medical Care AG & Co. KGaA's insider trading history. Receive FMS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Fresenius Medical Care AG & Co. KGaA and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. FMS Stock News HeadlinesJefferies Remains a Sell on Fresenius Medical Care AG & Co. KGaA (0H9X)August 9, 2026 | theglobeandmail.comBernstein Keeps Their Hold Rating on Fresenius Medical Care AG & Co. KGaA (0H9X)August 9, 2026 | theglobeandmail.comThe REAL Reason Trump is Invading IranFor a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Because my research has led me to believe we’re risking World War 3 with Iran for a completely different reason.September 13 at 1:00 AM | Banyan Hill Publishing (Ad)Fresenius Medical Care AG 2026 Q2 - Results - Earnings Call PresentationAugust 7, 2026 | seekingalpha.comFresenius Medical Care AG & Co. KGaA Q2 2026 Earnings Call SummaryAugust 5, 2026 | finance.yahoo.comFresenius Medical Care AG (FMS) Q2 2026 Earnings Call TranscriptAugust 4, 2026 | seekingalpha.comFresenius Medical Care Shares Drop After U.S. Treatment Volumes Fall FurtherAugust 4, 2026 | wsj.comKioxia Showcases Flash Storage Innovations for the AI Era at FMS 2026August 4, 2026 | businesswire.comSee More Headlines FMS Stock Analysis - Frequently Asked Questions How have FMS shares performed this year? Fresenius Medical Care AG & Co. KGaA's stock was trading at $23.84 at the beginning of the year. Since then, FMS shares have decreased by 6.2% and is now trading at $22.3550. How were Fresenius Medical Care AG & Co. KGaA's earnings last quarter? Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) issued its quarterly earnings results on Monday, August, 3rd. The company reported $0.66 earnings per share for the quarter, beating analysts' consensus estimates of $0.62 by $0.04. The business had revenue of $5.55 billion for the quarter, compared to the consensus estimate of $5.48 billion. Fresenius Medical Care AG & Co. KGaA had a net margin of 4.83% and a trailing twelve-month return on equity of 9.28%. Read the conference call transcript. Does Fresenius Medical Care AG & Co. KGaA have any subsidiaries? Fresenius Medical Care AG & Co. KGaA subsidiaries include these companies: NxStage Medical. Who are Fresenius Medical Care AG & Co. KGaA's major shareholders? Fresenius Medical Care AG & Co. KGaA's top institutional shareholders include Tidal Investments LLC (0.02%), Sequoia Financial Advisors LLC (0.01%), GAMMA Investing LLC and DMC Group LLC. How do I buy shares of Fresenius Medical Care AG & Co. KGaA? Shares of FMS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Fresenius Medical Care AG & Co. KGaA own? Based on aggregate information from My MarketBeat watchlists, some other companies that Fresenius Medical Care AG & Co. KGaA investors own include NVIDIA (NVDA), Broadcom (AVGO), Meta Platforms (META), Energy Transfer (ET), AbbVie (ABBV), GE Aerospace (GE) and Adobe (ADBE). Company Calendar Last Earnings8/03/2026Today9/13/2026Investor update10/12/2026Next Earnings (Estimated)11/03/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (2d) 1-Year History Sep 25 Dec 25 Mar 26 Jun 26 Sep 26 As of 2 days ago, FMS's financial health entered the Green zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNYSE SectorHealthcare Industry Healthcare Providers & Services Sub-IndustryHealthcare Services Current SymbolNYSE:FMS CIK1333141 Webwww.freseniusmedicalcare.com Phone(496) 172-6090Fax49-6172-609-2301Employees1,488Year Founded1912Price Target and Rating Average Price Target for Fresenius Medical Care AG & Co. KGaA$23.57 High Price Target$25.80 Low Price Target$19.90 Potential Upside/Downside+5.4%Consensus RatingReduce Rating Score (0-4)1.55 Research Coverage11 Analysts Profitability EPS (Trailing Twelve Months)$1.93 Trailing P/E Ratio11.58 Forward P/E Ratio9.94 P/E Growth4.15Net Income$1.11 billion Net Margins4.83% Pretax Margin7.67% Return on Equity9.28% Return on Assets4.16% Debt Debt-to-Equity Ratio0.43 Current Ratio1.07 Quick Ratio0.75 Sales & Book Value Annual Sales$22.20 billion Price / Sales0.54 Cash Flow$5.56 per share Price / Cash Flow4.02 Book Value$28.93 per share Price / Book0.77Miscellaneous Outstanding Shares537,130,000Free FloatN/AMarket Cap$12.01 billion OptionableOptionable Beta0.76 Social Links The Best Nuclear Energy Stocks to BuyNuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.Get This Free Report This page (NYSE:FMS) was last updated on 9/13/2026 by MarketBeat.com Staff. From Our PartnersALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredThese gold assets are priced for $1,800 gold [it's over $4,000]Gold's major miners are generating record free cash flow, with margins as high as 75 percent even after gold's...Golden Portfolio | SponsoredYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...Profits Run | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fresenius Medical Care AG & Co. KGaA Please log in to your account or sign up in order to add this asset to your watchlist. Share Fresenius Medical Care AG & Co. KGaA With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free FMS Stock Alerts